National HealthCare (NYSEAMERICAN:NHC) CEO Stephen Fowler Flatt Sells 1,500 Shares

Key Points

• CEO Stephen Fowler Flatt sold 1,500 NHC shares at an average price of $237.08, receiving $355,620. Following the sale, he owned 65,487 shares, a 2.24% reduction in his position.
• National HealthCare shares rose 1.2% to $236.75 and were near their 52-week high of $239.29. The company reported quarterly revenue of $408.03 million and earnings of $1.74 per share.
• The company announced a quarterly dividend of $0.67 per share, equivalent to an annualized $2.68 payout and a 1.1% yield. Analysts’ consensus rating is “Buy,” while institutional investors own 56.44% of the stock.

National HealthCare Corporation (NYSEAMERICAN:NHC - Get Free Report) CEO Stephen Fowler Flatt sold 1,500 shares of the business's stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $237.08, for a total transaction of $355,620.00. Following the completion of the transaction, the chief executive officer owned 65,487 shares in the company, valued at $15,525,657.96. The trade was a 2.24% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

National HealthCare Stock Up 1.2%

Shares of NYSEAMERICAN:NHC traded up $2.71 during midday trading on Thursday, hitting $236.75. 114,463 shares of the stock traded hands, compared to its average volume of 112,167. The business's 50 day moving average is $215.00 and its two-hundred day moving average is $186.44. The stock has a market capitalization of $3.71 billion, a PE ratio of 26.63 and a beta of 0.61. National HealthCare Corporation has a one year low of $109.81 and a one year high of $239.29.

National HealthCare (NYSEAMERICAN:NHC - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $1.74 earnings per share (EPS) for the quarter. National HealthCare had a return on equity of 10.03% and a net margin of 9.00%.The company had revenue of $408.03 million for the quarter.

National HealthCare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.67 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $2.68 annualized dividend and a yield of 1.1%. National HealthCare's dividend payout ratio (DPR) is 61.89%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Robert W. Baird raised National HealthCare to a "strong-buy" rating in a research note on Monday, May 18th. The Goldman Sachs Group raised National HealthCare to a "strong-buy" rating in a research note on Monday, May 18th. BMO Capital Markets upgraded shares of National HealthCare to a "hold" rating in a report on Monday, May 18th. Finally, Royal Bank Of Canada raised shares of National HealthCare to a "hold" rating in a research report on Monday, May 18th. Two equities research analysts have rated the stock with a Strong Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Buy".

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in NHC. Royal Bank of Canada boosted its position in shares of National HealthCare by 53.6% during the first quarter. Royal Bank of Canada now owns 2,724 shares of the company's stock valued at $253,000 after purchasing an additional 950 shares in the last quarter. AQR Capital Management LLC raised its holdings in National HealthCare by 1.7% in the first quarter. AQR Capital Management LLC now owns 16,080 shares of the company's stock worth $1,492,000 after purchasing an additional 262 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in National HealthCare by 3.1% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,247 shares of the company's stock worth $858,000 after purchasing an additional 281 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in National HealthCare by 7.1% during the first quarter. Goldman Sachs Group Inc. now owns 73,772 shares of the company's stock valued at $6,846,000 after buying an additional 4,879 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in National HealthCare by 18.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 30,246 shares of the company's stock valued at $2,807,000 after buying an additional 4,628 shares during the period. Hedge funds and other institutional investors own 56.44% of the company's stock.

National HealthCare Company Profile

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source